세계의 헬스케어 디스펜싱 시스템 시장 : 유형별, 재료별, 용도별, 최종사용자별, 지역별 - 예측(-2030년)

The healthcare dispensing systems market is projected to reach USD 6.27 billion by 2030 from USD 4.61 billion in 2025, at a CAGR of 6.3% during the forecast period. The growing demand for precision, automation, and efficiency in life sciences and clinical applications drives pharmaceutical and biotechnology companies to shift toward high-throughput screening and personalized medicine. As a result, there is a rising need for accurate and contamination-free liquid handling systems. Concerns about advanced dispensing systems, high costs, and integration issues with other laboratory systems can hinder the growth of the healthcare dispensing systems market to some extent over the forecast period.

"Diagnostic & Point-of-care testing management is the fastest growing application segment in the healthcare dispensing systems market during the forecast period."

By application, the healthcare dispensing systems market is segmented into pharmaceutical & biotechnology, diagnostic & point-of-care testing management, medical device manufacturing, pharmacy management, and other applications. Among these, the diagnostic & point-of-care testing management is the fastest-growing segment, driven by the increasing demand for rapid, decentralized testing and the global focus on early disease detection. This segment covers applications such as lateral flow assays (LFAs), PCR and NAAT tests, ELISA, microarrays, and microfluidic devices, each requiring accurate and repeatable dispensing of reagents and samples. Growth is fueled by the expansion of molecular diagnostics, rising infectious disease surveillance, and the growing availability of compact, high-throughput testing platforms. The need for precision, speed, and automation in producing consistent diagnostic results has led to the widespread adoption of automated dispensing systems that reduce variability, ensure traceability, and support large-scale manufacturing of test kits.

"Liquids are the fastest growing segment in the healthcare dispensing systems market, by dispensing material, during the forecast period."

By dispensing material, the healthcare dispensing systems market is segmented into liquids; powders, granules, lyophilized materials; and other dispensing materials. Among these, the liquid segment is projected to grow at the fastest rate during the forecast period due to its critical role in diagnostic, pharmaceutical, and research applications. Liquid dispensing systems are essential for accurately handling reagents, buffers, biological samples, and drug formulations in high-throughput environments. Their precision, speed, and compatibility with automated systems make them indispensable in clinical diagnostics (e.g., ELISA, PCR), pharmaceutical R&D, and point-of-care testing workflows. The increasing demand for automated liquid handling, driven by expanding test volumes, biologics manufacturing, and personalized medicine, has significantly boosted adoption. Additionally, advancements in non-contact and tipless dispensing technologies have enabled greater accuracy and minimized contamination, supporting applications that require stringent quality control. As automation, digitalization, and throughput optimization continue to reshape healthcare and laboratory operations, liquid dispensing systems emerge as a prominent technology, providing scalable, efficient, and compliant fluid handling solutions across diverse end users segments.

"The Asia Pacific region is expected to register the highest growth rate in the healthcare dispensing systems market during the forecast period."

The global healthcare dispensing systems market is segmented into five major regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2024, the Asia Pacific is expected to register the fastest growth in healthcare dispensing systems during the forecast period. This surge is primarily attributed to increased government funding, ongoing expansion in pharmaceutical and diagnostic manufacturing, and the adoption of automation technologies in countries such as China, India, South Korea, and Singapore. Additionally, favorable manufacturing policies, rising foreign direct investment in medtech and biotech sectors, and increased clinical research activity are creating strong demand for high-throughput, automated dispensing solutions. Combined with a focus on improving healthcare accessibility and efficiency, these factors are expected to significantly drive the growth of the healthcare dispensing systems market in Asia Pacific.

The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1 (41%), Tier 2 (31%), and Tier 3 (28%)
• By Designation - C-level Executives (44%), Director-level (31%), and Others (25%)
• By Region - North America (45%), Europe (28%), Asia Pacific (20%), Latin America (4%), Middle East & Africa (3%)

Key Players

The prominent players in this market are Nordson Corporation (US), DH Life Sciences, LLC (US), ABB (Switzerland), Fisnar (US), PARKER HANNIFIN CORP (US), BioDot (US), Thermo Fisher Scientific Inc. (US), bdtronic (Germany), Agilent Technologies, Inc. (US), Hamilton Company (US), Graco Inc. (US), Imagene Technology Inc (US), Harro Hofliger Verpackungsmaschinen GmbH (Germany), Tecan Trading AG (Switzerland), IVEK Corporation (US), Perkinelmer (US), QIAGEN (Germany), Coperion GmbH (Germany), Ascential Technologies (US), and and LGC Biosearch Technologies (UK). Players adopted organic as well as inorganic growth strategies such as product launches and enhancements, and investments, partnerships, collaborations, joint ventures, funding, acquisition, expansions, agreements, contracts, and alliances to increase their offerings, cater to the unmet needs of customers, increase their profitability, and expand their presence in the global market.

Research Coverage

• The report studies the healthcare dispensing systems market based on type, dispensing material, application, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro-markets with respect to their growth trends, prospects, and contributions to the total healthcare dispensing systems market.
• The report forecasts the revenue of market segments with respect to five major regions.

Reasons to Buy the Report

The report can help established firms, as well as new entrants/smaller firms, gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or a combination of the five strategies mentioned below.

This report provides insights into the following pointers:

• Analysis of key drivers (increasing demand for automation and precision in pharmaceutical and diagnostic workflows, rising adoption of point-of-care and decentralized testing platforms, growing need for high-throughput testing solutions in response to global health challenges, ongoing advancements in liquid handling and non-contact dispensing technologies, expansion of R&D and manufacturing infrastructure by biotech and medtech companies, supportive government initiatives for domestic manufacturing, and the push for digital transformation in clinical laboratories), restraints (high capital investment for advanced dispensing systems, limited adoption in low-resource settings, and technical complexity requiring skilled personnel), opportunities (rising outsourcing of diagnostic manufacturing to contract service providers, increasing investments in personalized medicine and biologics requiring precise micro dispensing, rapid growth in Asia Pacific healthcare infrastructure, demand for integrated cloud-based dispensing systems, and increased use of modular systems in flexible lab automation environments), and challenges (stringent regulatory validation processes, interoperability issues between dispensing systems and lab information systems, supply chain disruptions affecting critical dispensing components, and resistance from traditional labs in adopting automated workflows) influencing the growth of healthcare dispensing systems market).
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and product launches in the healthcare dispensing systems market.
• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various types of healthcare dispensing systems across regions.
• Market Diversification: Exhaustive information about products, untapped regions, recent developments, and investments in the healthcare dispensing systems market.
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the healthcare dispensing systems market.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE
  • 1.3.2 INCLUSIONS & EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Breakdown of primary sources
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN & DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 MARKET SIZING ASSUMPTIONS
  • 2.4.2 OVERALL STUDY ASSUMPTIONS
• 2.5 RISK ASSESSMENT
• 2.6 RESEARCH LIMITATIONS
  • 2.6.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.6.2 SCOPE-RELATED LIMITATIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 HEALTHCARE DISPENSING SYSTEMS MARKET OVERVIEW
• 4.2 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION
• 4.3 NORTH AMERICA: HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER & REGION
• 4.4 HEALTHCARE DISPENSING SYSTEMS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
• 4.5 HEALTHCARE DISPENSING SYSTEMS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
  • 5.1.1 DRIVERS
    • 5.1.1.1 Innovation in artificial intelligence and robotic systems
    • 5.1.1.2 Biotech and medtech R&D expansion
    • 5.1.1.3 Workflow optimization and lab digitization
    • 5.1.1.4 Government incentives for advanced manufacturing
  • 5.1.2 RESTRAINTS
    • 5.1.2.1 High cost of healthcare dispensing systems
    • 5.1.2.2 Regulatory and validation burdens
    • 5.1.2.3 Limited infrastructure in emerging markets
  • 5.1.3 OPPORTUNITIES
    • 5.1.3.1 Growing demand from emerging biotech hubs
    • 5.1.3.2 Growing partnerships and collaborations
    • 5.1.3.3 Increasing healthcare spending across regions
  • 5.1.4 CHALLENGES
    • 5.1.4.1 System integration challenges with existing laboratory infrastructure
    • 5.1.4.2 Shortage of skilled workforce for operating advanced labs
• 5.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
• 5.3 INDUSTRY TRENDS
  • 5.3.1 AUTOMATION AND ROBOTICS ADOPTION
  • 5.3.2 AI AND MACHINE LEARNING INTEGRATION
• 5.4 ECOSYSTEM ANALYSIS
• 5.5 VALUE CHAIN ANALYSIS
• 5.6 TECHNOLOGY ANALYSIS
  • 5.6.1 KEY TECHNOLOGIES
    • 5.6.1.1 Non-contact dispensing technologies
    • 5.6.1.2 Pressure-based microfluidic dispensing
    • 5.6.1.3 Robotic automation & vision systems
  • 5.6.2 COMPLEMENTARY TECHNOLOGIES
    • 5.6.2.1 Laboratory information management systems (LIMS)
    • 5.6.2.2 Computer-aided design and manufacturing (CAD/CAM) systems
  • 5.6.3 ADJACENT TECHNOLOGIES
    • 5.6.3.1 Digital twin technology
    • 5.6.3.2 3D printing in healthcare dispensing ecosystems
    • 5.6.3.3 AI-driven predictive maintenance for dispensing systems
• 5.7 REGULATORY ANALYSIS
  • 5.7.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.7.2 REGULATORY ANALYSIS
    • 5.7.2.1 North America
    • 5.7.2.2 Europe
    • 5.7.2.3 Asia Pacific
    • 5.7.2.4 Middle East & Africa
    • 5.7.2.5 Latin America
• 5.8 PRICING ANALYSIS
  • 5.8.1 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS, BY PRODUCT (2024)
  • 5.8.2 INDICATIVE PRICING FOR HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION, 2024
• 5.9 PORTER'S FIVE FORCES ANALYSIS
  • 5.9.1 INTENSITY OF COMPETITIVE RIVALRY
  • 5.9.2 BARGAINING POWER OF BUYERS
  • 5.9.3 THREAT OF SUBSTITUTES
  • 5.9.4 THREAT OF NEW ENTRANTS
  • 5.9.5 BARGAINING POWER OF SUPPLIERS
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TRENDS FOR HEALTHCARE DISPENSING SYSTEMS MARKET
  • 5.10.2 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR HEALTHCARE DISPENSING SYSTEMS MARKET
  • 5.10.3 MAJOR PATENTS IN HEALTHCARE DISPENSING SYSTEMS MARKET
• 5.11 KEY STAKEHOLDERS & BUYING CRITERIA
  • 5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.11.2 KEY BUYING CRITERIA
• 5.12 END-USER ANALYSIS
  • 5.12.1 UNMET NEEDS
  • 5.12.2 END-USER EXPECTATIONS
• 5.13 KEY CONFERENCES & EVENTS, 2025-2026
• 5.14 CASE STUDY ANALYSIS
• 5.15 TRADE ANALYSIS
  • 5.15.1 IMPORT SCENARIO (HS CODE 8413)
  • 5.15.2 EXPORT SCENARIO (HS CODE 8413)
• 5.16 INVESTMENT & FUNDING SCENARIO
• 5.17 IMPACT OF 2025 US TARIFFS ON HEALTHCARE DISPENSING SYSTEMS MARKET
  • 5.17.1 KEY TARIFF RATES
  • 5.17.2 PRICE IMPACT ANALYSIS
  • 5.17.3 IMPACT ON COUNTRY/REGION
    • 5.17.3.1 US
    • 5.17.3.2 Europe
    • 5.17.3.3 APAC
  • 5.17.4 IMPACT ON END-USE INDUSTRIES

6 HEALTHCARE DISPENSING SYSTEMS MARKET, BY TYPE

• 6.1 INTRODUCTION
• 6.2 AUTOMATIC DISPENSING SYSTEMS
  • 6.2.1 GROWING DEMAND FOR PRECISION, STERILITY, AND LAB AUTOMATION TO BOOST ADOPTION OF AUTOMATIC DISPENSING SYSTEMS
• 6.3 SEMI-AUTOMATIC DISPENSING SYSTEMS
  • 6.3.1 RISING R&D AND MID-VOLUME LAB DEMAND TO DRIVE DEMAND FOR COST-EFFECTIVE SEMI-AUTOMATED DISPENSING SYSTEMS
• 6.4 STANDALONE/MANUAL DISPENSING SYSTEMS
  • 6.4.1 VITAL ROLE OF MANUAL DISPENSING TOOLS IN LOW-RESOURCE, HIGH-CUSTOMIZATION LAB SETTINGS TO SUPPORT MARKET GROWTH
• 6.5 OEM/DISPENSING COMPONENTS
  • 6.5.1 PUMPS
    • 6.5.1.1 Ability of precision pumps to power sterile, compliant fluid handling across healthcare workflows to drive growth
  • 6.5.2 VALVES & NOZZLES
    • 6.5.2.1 Ability of valves & nozzles to enable precision, contamination-free fluid control in automated dispensing to boost market
  • 6.5.3 CONTROL SYSTEMS
    • 6.5.3.1 Ability of control systems to drive intelligent, compliant automation in healthcare dispensing to contribute to growth
  • 6.5.4 OTHER OEM COMPONENTS

7 HEALTHCARE DISPENSING SYSTEMS MARKET, BY MATERIAL

• 7.1 INTRODUCTION
• 7.2 LIQUIDS
  • 7.2.1 REAGENTS
    • 7.2.1.1 Growing automation needs in diagnostics, genomics, and biomanufacturing to boost demand for reagent dispensing systems
  • 7.2.2 BUFFERS
    • 7.2.2.1 High demand for scalable, validated workflows in biologics and diagnostics to boost market for buffer dispensing systems
  • 7.2.3 ANTIBODIES
    • 7.2.3.1 Rising demand for ultra-precise diagnostic and therapeutic applications to boost demand for antibody dispensing systems
  • 7.2.4 OTHER LIQUIDS
• 7.3 POWDERS, GRANULES, AND LYOPHILIZED MATERIALS
  • 7.3.1 CAKES
    • 7.3.1.1 Growing demand for high-precision injectable and diagnostic products to boost market for lyophilized cake dispensing
  • 7.3.2 LYOBEADS
    • 7.3.2.1 Ability of lyobeads to power cold chain-free diagnostics and therapeutics to drive growth
  • 7.3.3 OTHER POWDERS, GRANULES, AND LYOPHILIZED MATERIALS
• 7.4 OTHER MATERIALS

8 HEALTHCARE DISPENSING SYSTEMS MARKET, BY APPLICATION

• 8.1 INTRODUCTION
• 8.2 PHARMACEUTICAL & BIOTECHNOLOGY
  • 8.2.1 R&D
    • 8.2.1.1 Pivotal role of R&D in precise dispensing systems to support growth
  • 8.2.2 MANUFACTURING & QA/QC
    • 8.2.2.1 Advancing quality control with intelligent dispensing in pharma & biotech manufacturing to fuel growth
• 8.3 DIAGNOSTICS & POC TESTING
  • 8.3.1 LATERAL FLOW ASSAYS & RAPID TESTS
    • 8.3.1.1 Ability of these tests to enable scalable production with precision dispensing systems to boost market
  • 8.3.2 PCR & NUCLEIC ACID TESTS
    • 8.3.2.1 Ability of dispensing systems to advance PCR & NAAT efficiency to fuel growth
  • 8.3.3 IMMUNOASSAYS & ELISA TESTS
    • 8.3.3.1 Ability of automated dispensing systems to power high-throughput immunoassays to propel growth
  • 8.3.4 MICROARRAYS
    • 8.3.4.1 High-density assay precision with advanced dispensing systems to drive demand
  • 8.3.5 IMMUNOBLOTS
    • 8.3.5.1 Growing need to automate immunoblot workflows to drive market
  • 8.3.6 MICROFLUIDICS & LAB-ON-A-CHIP TESTS
    • 8.3.6.1 Advantages of dispensing systems in microfluidic and lab-on-a-chip technologies to support market
  • 8.3.7 OTHER DIAGNOSTICS & POC TESTING APPLICATIONS
• 8.4 MEDICAL DEVICE MANUFACTURING
  • 8.4.1 DRUG DELIVERY DEVICES
    • 8.4.1.1 Advantages such as precision filling and coating with advanced dispensing systems to boost market
  • 8.4.2 IMPLANTABLE MEDICAL DEVICES
    • 8.4.2.1 Growing need for dispensing of coatings, drug layers, and biocompatible materials to support market
  • 8.4.3 SURGICAL INSTRUMENTS & WOUND CARE DEVICES
    • 8.4.3.1 Ability of dispensing systems to drive quality and sterility in surgical and wound care devices to fuel growth
  • 8.4.4 DIAGNOSTIC TEST KIT MANUFACTURING
    • 8.4.4.1 Vital role of dispensing technologies in supporting medical-grade devices to drive growth
  • 8.4.5 OTHER MEDICAL DEVICE MANUFACTURING APPLICATIONS
• 8.5 PHARMACY MANAGEMENT
  • 8.5.1 INCREASING INTEGRATION OF DISPENSING SYSTEMS IN PHARMACY MANAGEMENT TO DRIVE GROWTH
• 8.6 OTHER APPLICATIONS

9 HEALTHCARE DISPENSING SYSTEMS MARKET, BY END USER

• 9.1 INTRODUCTION
• 9.2 HEALTHCARE PROVIDERS
  • 9.2.1 HOSPITALS
    • 9.2.1.1 High test volumes and strong push for automation to boost market growth
  • 9.2.2 DIAGNOSTIC LABS
    • 9.2.2.1 Need for precise, high-throughput dispensing in clinical testing to drive demand in diagnostic labs
  • 9.2.3 OUTPATIENT SETTINGS
    • 9.2.3.1 Need for patient safety in outpatient settings to boost segmental growth
  • 9.2.4 HOME HEALTHCARE, LONG-TERM CARE, AND ASSISTED LIVING FACILITIES
    • 9.2.4.1 Need to support decentralized, high-throughput care and ensure regulatory compliance to boost adoption
  • 9.2.5 PHARMACIES
    • 9.2.5.1 Growing need for technology to assist with faster prescription filling and medication dispensing to drive market growth
  • 9.2.6 OTHER HEALTHCARE PROVIDERS
• 9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
  • 9.3.1 GROWING IMPORTANCE OF AUTOMATION TO ENHANCE DRUG DEVELOPMENT SPEED AND ACCURACY TO BOOST DEMAND
• 9.4 MEDTECH COMPANIES
  • 9.4.1 GROWING ADOPTION OF PRECISION DISPENSING SYSTEMS TO SUPPORT DEVICE MINIATURIZATION
• 9.5 OTHER END USERS

10 HEALTHCARE DISPENSING SYSTEMS MARKET, BY REGION

• 10.1 INTRODUCTION
• 10.2 NORTH AMERICA
  • 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 10.2.2 US
    • 10.2.2.1 US to dominate North American healthcare dispensing systems market
  • 10.2.3 CANADA
    • 10.2.3.1 Strong demand for pharmacy automation to propel market
• 10.3 EUROPE
  • 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 10.3.2 GERMANY
    • 10.3.2.1 Germany to dominate European healthcare dispensing systems market during forecast period
  • 10.3.3 UK
    • 10.3.3.1 Strong support for life science R&D and well-developed infrastructure to aid market
  • 10.3.4 FRANCE
    • 10.3.4.1 Increasing investment in R&D and funding for life sciences to drive growth
  • 10.3.5 ITALY
    • 10.3.5.1 Advancements in laboratory systems to drive growth
  • 10.3.6 SPAIN
    • 10.3.6.1 Expanding medical diagnostics research to propel market growth
  • 10.3.7 REST OF EUROPE
• 10.4 ASIA PACIFIC
  • 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 10.4.2 CHINA
    • 10.4.2.1 China to grow at highest growth rate during forecast period
  • 10.4.3 JAPAN
    • 10.4.3.1 Japan to dominate Asia Pacific healthcare dispensing systems market
  • 10.4.4 INDIA
    • 10.4.4.1 Expansion of biotech sector, coupled with supportive government policies, to fuel market growth
  • 10.4.5 REST OF ASIA
• 10.5 LATIN AMERICA
  • 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 10.5.2 BRAZIL
    • 10.5.2.1 Growing public and private initiatives supporting scientific research to drive growth
  • 10.5.3 MEXICO
    • 10.5.3.1 Thriving pharmaceutical industry to drive market
  • 10.5.4 REST OF LATIN AMERICA
• 10.6 MIDDLE EAST & AFRICA
  • 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 10.6.2 GCC COUNTRIES
    • 10.6.2.1 Improvements in healthcare infrastructure to support market growth
  • 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

• 11.1 OVERVIEW
• 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
• 11.3 REVENUE ANALYSIS, 2020-2024
• 11.4 MARKET SHARE ANALYSIS, 2024
• 11.5 RANKING OF KEY MARKET PLAYERS
• 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 11.6.1 STARS
  • 11.6.2 EMERGING LEADERS
  • 11.6.3 PERVASIVE PLAYERS
  • 11.6.4 PARTICIPANTS
  • 11.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024
    • 11.6.5.1 Company footprint
    • 11.6.5.2 Region footprint
    • 11.6.5.3 Type footprint
    • 11.6.5.4 Material footprint
    • 11.6.5.5 Application footprint
    • 11.6.5.6 End-user footprint
• 11.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 11.7.1 PROGRESSIVE COMPANIES
  • 11.7.2 RESPONSIVE COMPANIES
  • 11.7.3 DYNAMIC COMPANIES
  • 11.7.4 STARTING BLOCKS
  • 11.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 11.7.5.1 Detailed list of key startups/SMEs
    • 11.7.5.2 Competitive benchmarking of startups/SMEs
• 11.8 COMPANY VALUATION & FINANCIAL METRICS
• 11.9 BRAND/PRODUCT COMPARISON
• 11.10 COMPETITIVE SCENARIO
  • 11.10.1 PRODUCT LAUNCHES
  • 11.10.2 DEALS
  • 11.10.3 EXPANSIONS

12 COMPANY PROFILES

• 12.1 KEY PLAYERS
  • 12.1.1 NORDSON CORPORATION
    • 12.1.1.1 Business overview
    • 12.1.1.2 Products offered
    • 12.1.1.3 Recent developments
      • 12.1.1.3.1 Product launches
      • 12.1.1.3.2 Deals
      • 12.1.1.3.3 Expansions
    • 12.1.1.4 MnM view
      • 12.1.1.4.1 Right to win
      • 12.1.1.4.2 Strategic choices
      • 12.1.1.4.3 Weaknesses & competitive threats
  • 12.1.2 AGILENT TECHNOLOGIES, INC.
    • 12.1.2.1 Business overview
    • 12.1.2.2 Products offered
    • 12.1.2.3 Recent developments
      • 12.1.2.3.1 Product launches
      • 12.1.2.3.2 Deals
    • 12.1.2.4 MnM view
      • 12.1.2.4.1 Right to win
      • 12.1.2.4.2 Strategic choices
      • 12.1.2.4.3 Weaknesses & competitive threats
  • 12.1.3 DANAHER CORPORATION
    • 12.1.3.1 Business overview
    • 12.1.3.2 Products offered
    • 12.1.3.3 Recent developments
      • 12.1.3.3.1 Deals
    • 12.1.3.4 MnM view
      • 12.1.3.4.1 Right to win
      • 12.1.3.4.2 Strategic choices
      • 12.1.3.4.3 Weaknesses & competitive threats
  • 12.1.4 THERMO FISHER SCIENTIFIC INC.
    • 12.1.4.1 Business overview
    • 12.1.4.2 Products offered
    • 12.1.4.3 Recent developments
      • 12.1.4.3.1 Expansions
    • 12.1.4.4 MnM view
      • 12.1.4.4.1 Right to win
      • 12.1.4.4.2 Strategic choices
      • 12.1.4.4.3 Weaknesses & competitive threats
  • 12.1.5 BIODOT
    • 12.1.5.1 Business overview
    • 12.1.5.2 Products offered
    • 12.1.5.3 Recent developments
      • 12.1.5.3.1 Product launches
      • 12.1.5.3.2 Deals
    • 12.1.5.4 MnM view
      • 12.1.5.4.1 Right to win
      • 12.1.5.4.2 Strategic choices
      • 12.1.5.4.3 Weaknesses & competitive threats
  • 12.1.6 FISNAR
    • 12.1.6.1 Business overview
    • 12.1.6.2 Products offered
  • 12.1.7 PARKER-HANNIFIN CORPORATION
    • 12.1.7.1 Business overview
    • 12.1.7.2 Products offered
  • 12.1.8 BDTRONIC
    • 12.1.8.1 Business overview
    • 12.1.8.2 Products offered
  • 12.1.9 HAMILTON COMPANY
    • 12.1.9.1 Business overview
    • 12.1.9.2 Products offered
    • 12.1.9.3 Recent developments
      • 12.1.9.3.1 Product launches
      • 12.1.9.3.2 Deals
  • 12.1.10 GRACO INC.
    • 12.1.10.1 Business overview
    • 12.1.10.2 Products offered
    • 12.1.10.3 Recent developments
      • 12.1.10.3.1 Product launches
  • 12.1.11 REVVITY, INC.
    • 12.1.11.1 Business overview
    • 12.1.11.2 Products offered
  • 12.1.12 HARRO HOFLIGER VERPACKUNGSMASCHINEN GMBH
    • 12.1.12.1 Business overview
    • 12.1.12.2 Products offered
    • 12.1.12.3 Recent developments
      • 12.1.12.3.1 Deals
  • 12.1.13 TECAN TRADING AG
    • 12.1.13.1 Business overview
    • 12.1.13.2 Products offered
  • 12.1.14 IVEK CORPORATION
    • 12.1.14.1 Business overview
    • 12.1.14.2 Products offered
  • 12.1.15 IMAGENE TECHNOLOGY INC.
    • 12.1.15.1 Business overview
    • 12.1.15.2 Products offered
  • 12.1.16 QIAGEN
    • 12.1.16.1 Business overview
    • 12.1.16.2 Products offered
  • 12.1.17 BRAND GMBH + CO KG
    • 12.1.17.1 Business overview
    • 12.1.17.2 Products offered
  • 12.1.18 ASCENTIAL TECHNOLOGIES
    • 12.1.18.1 Business overview
    • 12.1.18.2 Products offered
    • 12.1.18.3 Recent developments
      • 12.1.18.3.1 Expansions
      • 12.1.18.3.2 Other developments
  • 12.1.19 LGC BIOSEARCH TECHNOLOGIES
    • 12.1.19.1 Business overview
    • 12.1.19.2 Products offered
    • 12.1.19.3 Recent developments
      • 12.1.19.3.1 Deals
  • 12.1.20 GILSON INCORPORATED
    • 12.1.20.1 Business overview
    • 12.1.20.2 Products offered
• 12.2 OTHER PLAYERS
  • 12.2.1 CLAREMONT BIOSOLUTIONS, LLC
  • 12.2.2 GUANGZHOU ASCEND PRECISION MACHINERY CO., LTD.
  • 12.2.3 RADETEC PTY LTD.
  • 12.2.4 BAODING CHUANGRUI PRECISION PUMP CO., LTD.
  • 12.2.5 ELVEFLOW

13 APPENDIX

• 13.1 DISCUSSION GUIDE
• 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 13.3 CUSTOMIZATION OPTIONS
• 13.4 RELATED REPORTS
• 13.5 AUTHOR DETAILS